REFERENCE TO A SEQUENCE LISTING SUBMITTED IN A COMPUTER READABLE FORMAT
The sequence listing written in the file 483620_SEQLST.txt is 18,070 bytes, and was created on Aug. 23, 2016 and is hereby incorporated by reference.
BACKGROUND OF THE INVENTION
Many drugs are required to be taken up by cells or
REFERENCE TO A SEQUENCE LISTING SUBMITTED IN A COMPUTER READABLE FORMAT
The sequence listing written in the file 413219_SEQLST.TXT is 18,027 bytes, and was created on Jun. 11, 2012 and is hereby incorporated by reference.
BACKGROUND OF THE INVENTION
Many drugs are required to be taken up by cells or
BACKGROUND OF THE INVENTION
Many drugs are required to be taken up by cells or pass through cells and/or be taken up by cellular organelles to reach their intended therapeutic target. Many larger molecules and some small ones by themselves have limited capacity to pass through cellular membranes.
BACKGROUND OF THE INVENTION
This invention relates to biotin derivatives of rapamycin and a method for using them for inducing immunosuppression; in the treatment of transplantation rejection, host vs. graft disease, autoimmune diseases, diseases of inflammation, solid tumors, fungal infections,
BACKGROUND OF THE INVENTION
Siderophores are low-molecular-weight high-affinity Fe(III) chelators that are biosynthesized and exported by bacteria, fungi, and plants during periods of nutrient limitation for acquiring this essential metal ion from the extracellular milieu..sup.1,2 Both
FIELD OF THE INVENTION
The present invention relates to compounds for targeting human or animal disease states characterized by aberrant expression of the intermediate filament type III proteins, such as vimentin, methods and compounds for detecting intermediate filament type III proteins, such as
BACKGOUND OF THE INVENTION
The present invention relates to a method for producing an oligosaccharide. The present invention also relates to a novel oligosaccharide and a pharmaceutical composition containing it.
Keratan sulfate is a glycosaminoglycan comprising, as a basic structure, N-acetyl
BACKGROUND OF THE INVENTION
Platinum complexes, the prototype being cisplatin (Cis-Pt), have been widely used as active anticancer agents (Ardizzoni et al., 1999; Nitiss, 2002) in a variety of human tumors, including testicular, ovarian, bladder carcinoma, head and neck, and non-small cell lung
The most complete medicinal herbs database backed by science
Works in 55 languages
Herbal cures backed by science
Herbs recognition by image
Interactive GPS map - tag herbs on location (coming soon)
Read scientific publications related to your search
Search medicinal herbs by their effects
Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against. *All information is based on published scientific research